Washington Trust Bank Edwards Lifesciences Corp Transaction History

Washington Trust Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$55.74 - $64.41 $32,830 - $37,937	-589 Closed	0 $0
Q1 2019 Apr 09, 2019	BUY	$47.89 - $64.05 $19,156 - $25,620	400 Added 211.64%	589 $112,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $3,656 - $4,642	-80 Reduced 29.74%	189 $33,000
Q3 2017 Oct 05, 2017	BUY	$36.29 - $38.83 $9,762 - $10,445	269	269 $29,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Washington Trust Bank with notifications on news.